Plasma heat shock protein 27 is associated with coronary artery disease, abdominal aortic aneurysm and peripheral artery disease.
Low protein levels of Hsp27 have been reported in atherosclerotic plaques. In addition, human studies have indicated that circulating Hsp27 levels are lower in coronary artery disease patients compared with controls. It remains, however, unclear whether this applies to other forms of atherosclerotic disease. Plasma Hsp27 from 280 subjects was examined by ELISA. The cohort included 80 coronary artery disease (CAD), 40 peripheral artery disease (PAD) and 80 abdominal aortic aneurysm (AAA) patients. Eighty elderly subjects, without any clinical history of vascular diseases, were used as a control group. Receiver operating curve (ROC) and logistic regression model analysis were performed to evaluate the potential value of Hsp27 as a circulating biomarker. Patients with atherosclerotic vascular diseases had significantly lower levels of Hsp27 than control subjects (p < 0.001). Moreover, Hsp27 was significantly lower in CAD patients than other atherosclerotic vascular disease groups (p < 0.001). There was no difference in Hsp27 levels between the AAA and PAD groups. Using the ROC-generated optimal cut-off values for Hsp27, logistic regression modeling indicated that low plasma Hsp27 was independently associated with the presence of multiple forms of atherosclerotic disease. In conclusion, circulating Hsp27 is significantly lower in patients with multiple forms of atherosclerotic arterial disease.
Department of Surgery, University of Otago, PO Box 913, Dunedin, New Zealand.
Cao
C
Jin
Department of Surgery, University of Otago, PO Box 913, Dunedin, New Zealand.
Victoria L
VL
Phillips
Department of Medicine, University of Otago, PO Box 913, Dunedin, New Zealand.
Michael Ja
MJ
Williams
Department of Surgery, University of Otago, PO Box 913, Dunedin, New Zealand.
Andre M
AM
van Rij
Department of Surgery, University of Otago, PO Box 913, Dunedin, New Zealand.
Gregory T
GT
Jones